Epidemiology, diagnosis and management of intracranial atherosclerotic disease

Jiann-Shing Jeng1, Sung-Chun Tang, Hon-Man Liu

  • 1Department of Neurology, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan. jsjeng@ntu.edu.tw

Insights

Intracranial atherosclerotic disease (ICAD) increases stroke risk, especially in certain ethnicities. Antiplatelet drugs are preferred over anticoagulants, while angioplasty/stenting shows promise but needs long-term data.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Intracranial atherosclerotic disease (ICAD) is a leading cause of ischemic stroke, disproportionately affecting Asian, black, and Hispanic populations.
  • Key risk factors for ICAD include hypertension, diabetes mellitus, and metabolic syndrome, contributing to a significant annual stroke risk of 10–20% in patients.
  • High-grade stenosis (70–99%) in ICAD patients elevates stroke recurrence risk, necessitating effective secondary prevention strategies.

Purpose of the Study:

  • To review current understanding and treatment strategies for intracranial atherosclerotic disease (ICAD).
  • To evaluate the role of antiplatelet therapy and emerging endovascular interventions like angioplasty and stenting in managing ICAD.
  • To highlight the need for further research, particularly high-quality randomized trials, to establish long-term benefits of interventions.

Main Methods:

  • Review of existing literature on intracranial atherosclerotic disease (ICAD) epidemiology, risk factors, and clinical outcomes.
  • Analysis of current secondary prevention guidelines, focusing on antiplatelet versus anticoagulant therapy.
  • Assessment of the efficacy and safety of endovascular treatments, including angioplasty and stenting for ICAD.

Main Results:

  • Antiplatelet agents remain the primary medical treatment for ICAD, with limited evidence supporting anticoagulants.
  • Angioplasty and stenting demonstrate high technical success and low periprocedural complication rates as an alternative to medical management.
  • Moderate rates of in-stent restenosis and uncertain long-term benefits necessitate further investigation into endovascular approaches.

Conclusions:

  • Effective secondary prevention for symptomatic ICAD patients is crucial due to high stroke recurrence rates.
  • While angioplasty and stenting offer a promising alternative for ICAD, long-term outcomes and restenosis rates require further evaluation.
  • High-quality randomized controlled trials comparing endovascular therapy with best medical therapy are essential for definitive treatment guidelines in ICAD.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...